Principal Financial Group’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49K Buy
+14,046
New +$45.3K ﹤0.01% 2134
2025
Q1
Sell
-12,499
Closed -$20.4K 2211
2024
Q4
$20.4K Buy
12,499
+135
+1% +$403 ﹤0.01% 2199
2024
Q3
$51.4K Sell
12,364
-13,417
-52% -$70.5K ﹤0.01% 2177
2024
Q2
$141K Sell
25,781
-10,613
-29% -$84.6K ﹤0.01% 2188
2024
Q1
$364K Sell
36,394
-2,834
-7% -$21.2K ﹤0.01% 2054
2023
Q4
$160K Sell
39,228
-3,436
-8% -$12.7K ﹤0.01% 2199
2023
Q3
$165K Buy
42,664
+4,928
+13% +$26.5K ﹤0.01% 2193
2023
Q2
$225K Sell
37,736
-103
-0.3% -$594 ﹤0.01% 2150
2023
Q1
$124K Buy
37,839
+2,298
+6% +$9.18K ﹤0.01% 2269
2022
Q4
$140K Buy
35,541
+4,505
+15% +$22K ﹤0.01% 2247
2022
Q3
$186K Buy
31,036
+5,193
+20% +$37.5K ﹤0.01% 2219
2022
Q2
$166K Sell
25,843
-10,856
-30% -$69.2K ﹤0.01% 2325
2022
Q1
$304K Sell
36,699
-135
-0.4% -$1.09K ﹤0.01% 2238
2021
Q4
$571K Buy
36,834
+19,315
+110% +$372K ﹤0.01% 2095
2021
Q3
$395K Buy
+17,519
New +$368K ﹤0.01% 2239

Other funds holding SANA

Principal Financial Group's SANA Position: Q2 2026 in Review

Principal Financial Group opened a new position in Sana Biotechnology (SANA) in Q2 2026: 14,046 shares worth $49K. The stake represents ﹤0.01% of the portfolio and ranks #2134 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in SANA as recently as Q4 2024.

Principal Financial Group first reported a position in SANA in Q3 2021 and has held it in 15 quarters since. The position peaked at $571K in Q4 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Principal Financial Group held 14,046 shares of Sana Biotechnology worth $49K as of Q2 2026.
  • Sana Biotechnology was a new Principal Financial Group position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2134 holding.
  • Principal Financial Group first reported a position in Sana Biotechnology in Q3 2021 and has held it in 15 quarters since.
  • Principal Financial Group's Sana Biotechnology position peaked at $571K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.